Building Tomorrow’s Health with Vision & Purpose
Innovator, Entrepreneur, Philanthropist.
Transforming Life Sciences, Empowering Communities.
Mihir Taneja is a driven leader in pharmaceuticals and biotechnology, combining strategic insight with a restless curiosity to deliver breakthroughs. From pioneering life-saving therapeutics to scaling companies from the ground up, his work reflects both commercial success and social conscience.
With degrees in Finance and Marketing from the University of Miami, Mihir has built multiple ventures in both public and private markets that challenge the status quo. He thrives where complex problems meet big vision: sterile injectables, orphan drugs, premium wound care, and more. His journey is always forward moving, not just in profits but in lives changed.
A Trailblazing Career
Throughout his career, Mihir Taneja has combined strategic vision with hands-on leadership to build and transform businesses in the pharmaceutical and life sciences sectors. His work spans from launching innovative therapies to scaling companies into industry leaders, always with a focus on raising standards, driving growth, and improving patient outcomes. These milestones reflect a career defined by innovation, resilience, and long-term impact.
A Legacy of Business Growth and Innovation
Co-founded one of the world's leading manufacturers of aseptic and terminally sterilized injectable medications, setting new standards in pharmaceutical production.
Pioneered novel therapeutics, including a preservative-free Epinephrine and the orphan drug Ablysinol for cardiac use.
Founder of CPN, a a biopharma company that revolutionized the wound care market with it proprietary sterilize Type II collagen dressings. The company was acquired within 4 years of inception.
Co-founded Lark, an industry leader in regenerative care; specializing in the development, manufacturing and commercialization of cell therapies and human cellular and tissue based products, including, perinatal mesenchymal stem cell (MSC) and exosomes.
Founder of Castun, a CRO focused on development of niche and novel therapeutics, utilizing the FDA 504(b)(2) regulatory pathways. Castun has been awarded several FDA approval that have been licensed off.
Co-founded Genlab, a Brazil based sterile injectable manufacture of peptides based products sold directly to consumers and health care providers.
Founder of Ashbury Capital, a pharmaceutical consultancy, focused on the acquisition, licensing and sales of distressed and underperforming drug assets.
Co-founded APS, one of the largest sterile 503A compound pharmacies in the country, specializing in longevity, ophthalmics and animal health. Acquired by a PE firm.
Co-founded Virtus, a specialty generic pharmaceutical company commercializing niche therapeutics. Was considered one of the fast growth generic pharmaceutical companies and was sold to PE within 5 years of inception.
Co-founder of Soma, a Govtech business, which was one of the first cloud based SAAS public safety software platforms, specializing in 911 dispatch, RMS. Sold to PE within 4 years of inception.
Co-founder of Ace, a IT managed services provider of infrastructure, co-location and virtual based hosting. Ace is a leader in streaming services, AI, blockchain and crypto hosting.
KMR is a healthcare consultancy focused on delivering innovative solutions across pharmaceuticals, biotechnology, medical sector. Its integrated approach combines science, technology, and commercialization delivery to create sustainable value for partners.
Maroon Wines - a family owned vineyard in Napa Valley, producing some of the most esteemed award winning Cabernet Sauvignon in Napa.
Co-founded Kaligia, a bioscience company pioneering the use of ramanspectrophy for non invasive testing of analytes. Created the first non blood test for A1C and blood sugar. Divestiture of the intellectual property portfolio.
Innovative Health Products - Founded Innovative Health, which was one of largest contract manufacture of nutraceutical and skincare are products. Acquired within 3 years.
Founded BEN, which was a pioneer in the functional food space. Launched the first protein 0 carbohydrate chip. Acquired within 5 years.
Co-Founded GeoPharma, which was NASDAQ listed. GeoPharma was multi faceted healthcare company specializing in pharmaceutical CMO and PBM services.
Ajenat is a family office and diversified holding company dedicated to managing private capital and investment portfolio. Ajenat has investments and holdings in oil and gas, real estate, aircrafts and sports entertainment.
A Commitment to Community
The Taneja Foundation
Mihir Taneja and the Taneja family are widely recognized in Tampa Bay for philanthropy that blends healthcare innovation with education. Through the Taneja Family Foundation, their landmark support helped Tampa General Hospital break ground on the new Taneja Surgical, Neuroscience & Transplant Tower, an academic-medicine pavilion designed to expand complex care, research, and training for the region. Their giving also enabled the creation of the Taneja Family Global Emerging Diseases Institute, a first-of-its-kind Florida facility launched during the pandemic to treat infectious diseases and advance research in collaboration with USF Health. This commitment is deeply personal for the family and honors a loved one’s memory by improving access to world-class care for others.
Beyond Tampa General and USF, the family’s healthcare philanthropy also includes AdventHealth Tampa’s Taneja Center for Surgery, a six-story state-of-the-art surgical tower that expands operating capacity, critical-care beds, and advanced technology for complex procedures. Collectively, the Tanejas’ giving accelerates care delivery, talent development, and translational research across the Tampa Medical & Research District and the broader region, an ongoing legacy of impact that Mihir champions through the foundation’s work.
The family’s focus on education is just as enduring. A transformational $10 million gift named the USF Health Taneja College of Pharmacy, elevating pharmacy education and workforce development for Florida. More recently, the family established the Taneja Endowment for Teaching Excellence in Specialized Instruction at Berkeley Preparatory School, strengthening teacher recruitment and support for more than 1,400 students. These investments reflect a long-view approach that empowers the next generation of clinicians, scientists, and educators to drive better outcomes for communities.